166 related articles for article (PubMed ID: 17522328)
21. Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa.
Lawn SD; Bangani N; Vogt M; Bekker LG; Badri M; Ntobongwana M; Dockrell HM; Wilkinson RJ; Wood R
BMC Infect Dis; 2007 Aug; 7():99. PubMed ID: 17725839
[TBL] [Abstract][Full Text] [Related]
22. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.
Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500
[TBL] [Abstract][Full Text] [Related]
23. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study.
Elliott AM; Hurst TJ; Balyeku MN; Quigley MA; Kaleebu P; French N; Biryahwaho B; Whitworth JA; Dockrell HM; Hayes RJ
Int J Tuberc Lung Dis; 1999 Mar; 3(3):239-47. PubMed ID: 10094326
[TBL] [Abstract][Full Text] [Related]
24. Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.
Dadaglio G; Morel S; Bauche C; Moukrim Z; Lemonnier FA; Van Den Eynde BJ; Ladant D; Leclerc C
Int Immunol; 2003 Dec; 15(12):1423-30. PubMed ID: 14645151
[TBL] [Abstract][Full Text] [Related]
25. T cell reactivity against mycolyl transferase antigen 85 of M. tuberculosis in HIV-TB coinfected subjects and in AIDS patients suffering from tuberculosis and nontuberculous mycobacterial infections.
Launois P; Drowart A; Bourreau E; Couppie P; Farber CM; Van Vooren JP; Huygen K
Clin Dev Immunol; 2011; 2011():. PubMed ID: 20936150
[TBL] [Abstract][Full Text] [Related]
26. Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppression.
Hammond AS; McConkey SJ; Hill PC; Crozier S; Klein MR; Adegbola RA; Rowland-Jones S; Brookes RH; Whittle H; Jaye A
J Infect Dis; 2008 Jan; 197(2):295-9. PubMed ID: 18194089
[TBL] [Abstract][Full Text] [Related]
27. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture.
Katial RK; Hershey J; Purohit-Seth T; Belisle JT; Brennan PJ; Spencer JS; Engler RJ
Clin Diagn Lab Immunol; 2001 Mar; 8(2):339-45. PubMed ID: 11238218
[TBL] [Abstract][Full Text] [Related]
28. The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
Churchyard GJ; Snowden MA; Hokey D; Dheenadhayalan V; McClain JB; Douoguih M; Pau MG; Sadoff J; Landry B
Vaccine; 2015 Apr; 33(15):1890-6. PubMed ID: 25698492
[TBL] [Abstract][Full Text] [Related]
29. Bioengineering of
Ladant D
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33499260
[TBL] [Abstract][Full Text] [Related]
30. The adenylate cyclase toxins of Bacillus anthracis and Bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling.
Rossi Paccani S; Benagiano M; Capitani N; Zornetta I; Ladant D; Montecucco C; D'Elios MM; Baldari CT
PLoS Pathog; 2009 Mar; 5(3):e1000325. PubMed ID: 19266022
[TBL] [Abstract][Full Text] [Related]
31. Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa.
Sutherland JS; Lalor MK; Black GF; Ambrose LR; Loxton AG; Chegou NN; Kassa D; Mihret A; Howe R; Mayanja-Kizza H; Gomez MP; Donkor S; Franken K; Hanekom W; Klein MR; Parida SK; Boom WH; Thiel BA; Crampin AC; Ota M; Walzl G; Ottenhoff TH; Dockrell HM; Kaufmann SH;
PLoS One; 2013; 8(9):e74080. PubMed ID: 24040170
[TBL] [Abstract][Full Text] [Related]
32. Human Immunodeficiency Virus Infection Impairs Th1 and Th17 Mycobacterium tuberculosis-Specific T-Cell Responses.
Murray LW; Satti I; Meyerowitz J; Jones M; Willberg CB; Ussher JE; Goedhals D; Hurst J; Phillips RE; McShane H; Vuuren CV; Frater J
J Infect Dis; 2018 May; 217(11):1782-1792. PubMed ID: 29546381
[TBL] [Abstract][Full Text] [Related]
33. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.
Fayolle C; Osickova A; Osicka R; Henry T; Rojas MJ; Saron MF; Sebo P; Leclerc C
J Virol; 2001 Aug; 75(16):7330-8. PubMed ID: 11462005
[TBL] [Abstract][Full Text] [Related]
34. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis.
Ewer K; Millington KA; Deeks JJ; Alvarez L; Bryant G; Lalvani A
Am J Respir Crit Care Med; 2006 Oct; 174(7):831-9. PubMed ID: 16799072
[TBL] [Abstract][Full Text] [Related]
35. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
[TBL] [Abstract][Full Text] [Related]
36. Frequencies of region of difference 1 antigen-specific but not purified protein derivative-specific gamma interferon-secreting T cells correlate with the presence of tuberculosis disease but do not distinguish recent from remote latent infections.
Hinks TS; Dosanjh DP; Innes JA; Pasvol G; Hackforth S; Varia H; Millington KA; Liu XQ; Bakir M; Soysal A; Davidson RN; Gunatheesan R; Lalvani A
Infect Immun; 2009 Dec; 77(12):5486-95. PubMed ID: 19752037
[TBL] [Abstract][Full Text] [Related]
37. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
38. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration.
Johnson JL; Nyole S; Okwera A; Whalen CC; Nsubuga P; Pekovic V; Huebner R; Wallis RS; Mugyenyi PN; Mugerwa RD; Ellner JJ
Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269
[TBL] [Abstract][Full Text] [Related]
39. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country.
Kang YA; Lee HW; Yoon HI; Cho B; Han SK; Shim YS; Yim JJ
JAMA; 2005 Jun; 293(22):2756-61. PubMed ID: 15941805
[TBL] [Abstract][Full Text] [Related]
40. The role of
Kisuya J; Chemtai A; Raballah E; Okumu W; Keter A; Ouma C
Pan Afr Med J; 2018; 31():166. PubMed ID: 31086619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
